Blogs

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

LA JOLLA, Calif., Jan. 14, 2025 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica" or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory...

Jan 14, 2025 | Health

ONLY AVAILABLE IN PAID PLANS.

Back to Health Page

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

'I was diagnosed with MND two years ago and have been robbed of everything since'

Cardinal Health expects profit for FY 2025 near top end of guidance

WELL Health Provides a Capital Allocation Update Reflecting the Addition of $100M in Annualized Revenue from Acquisitions Completed Since December 2024

Trellus Health to Bring Holistic Support to Patients, Working With a Pharmaceutical Company

Syantra, Inc. Welcomes STEM Advocate and Breast Cancer Conqueror Holly Smithson to Its Board of Directors

Bio-Thera Solutions Publishes Phase I Clinical Study Results for BAT4406F, an ADCC-Enhanced Fully Humanized Anti-CD20 Monoclonal Antibody, in Patients with Neuromyelitis Optica Spectrum Disorders

MIB Announces New Data and Analytics Service Providing Unique Insights into Life Insurance Application Activity

ScienceSoft Positioned as the Leader in the 2024 SPARK MatrixTM: Healthcare IT Services by QKS Group

Get the FASHION, BEAUTY, ENTERTAINMENT, FOOD
and more

NEWSLETTER SUBSCRIPTION

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

Get the FASHION, BEAUTY, ENTERTAINMENT, FOOD and more

Get the FASHION, BEAUTY, ENTERTAINMENT, FOOD
and more